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Background: Split-mouth randomized controlled trials (RCTs) are popular in oral health research. Meta-analyses
frequently include trials of both split-mouth and parallel-arm designs to derive combined intervention effects. However,
carry-over effects may induce bias in split- mouth RCTs. We aimed to assess whether intervention effect estimates differ
between split- mouth and parallel-arm RCTs investigating the same questions.
Methods: We performed a meta-epidemiological study. We systematically reviewed meta- analyses including both
split-mouth and parallel-arm RCTs with binary or continuous outcomes published up to February 2013. Two
independent authors selected studies and extracted data. We used a two-step approach to quantify the differences
between split-mouth and parallel-arm RCTs: for each meta-analysis. First, we derived ratios of odds ratios (ROR) for
dichotomous data and differences in standardized mean differences (ΔSMD) for continuous data; second, we pooled
RORs or ΔSMDs across meta-analyses by random-effects meta-analysis models.
Results: We selected 18 systematic reviews, for 15 meta-analyses with binary outcomes (28 split-mouth and 28
parallel-arm RCTs) and 19 meta-analyses with continuous outcomes (28 split-mouth and 28 parallel-arm RCTs).
Effect estimates did not differ between split-mouth and parallel-arm RCTs (mean ROR, 0.96, 95% confidence interval
0.52–1.80; mean ΔSMD, 0.08, −0.14–0.30).
Conclusions: Our study did not provide sufficient evidence for a difference in intervention effect estimates derived
from split-mouth and parallel-arm RCTs. Authors should consider including split-mouth RCTs in their meta-analyses with
suitable and appropriate analysis.
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In split-mouth randomized controlled trials (RCTs) in
oral health, experimental and control interventions are
randomly allocated to different areas in the oral cavity
(teeth, surfaces, arches, quadrants) [1-3]. As compared
with parallel-arm RCTs, split-mouth RCTs have the ad-
vantage that most of the variability of outcome among
patients is removed from the intervention effect esti-
mate for a potential increase in statistical power, each
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be better suited to determine patient preferences.
Many researchers in oral health research use the
split-mouth design. Therefore, systematic review authors
frequently include trials of both split-mouth and parallel-
group designs to derive combined intervention effects.
The rationale to include split-mouth RCTs is to use all the
available evidence. However, the split-mouth design may
lead to biased intervention effect estimates. For instance,
carry-over effects (ie, contamination or “spilling” of the
effects of one intervention from one site to another site)
may induce bias in split-mouth RCTs [4]. If the interven-
tions are delivered at different times, period effects may
also influence intervention effects. Moreover, the statistical
analysis of split-mouth differs from that of parallel-armCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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account [6-8]. Failure to consider the difference between
the two types of trials may result in unreliable inference
because the confidence interval for the true combined
effect will be incorrect. Lesaffre et al. suggested that inter-
vention effect estimates from split-mouth and parallel-arm
RCTs may not be the same and recommended separate
subgroup meta-analyses of split-mouth and parallel-arm
RCTs to investigate systematic differences [9].
In this meta-epidemiological study, we aimed to assess
if data from split-mouth RCTs were incorporated appro-
priately in meta-analyses and whether intervention effect
estimates differ between split-mouth and parallel-arm
RCTs in meta-analyses.
Methods
We performed a meta-epidemiological study to compare
intervention effect estimates between split-mouth RCTs
and parallel-arm RCTs. We identified meta-analyses that
included at least one split-mouth RCT and at least one
parallel-arm RCT assessing a variety of conditions and
interventions on binary or continuous outcomes. For
each selected meta- analysis, we compared intervention
effect estimates between split-mouth and parallel-arm
RCTs. In a second stage, results were summarized across
all meta-analyses.
Selection of meta-analyses, trials and outcomes
To identify eligible studies, we searched MEDLINE and
EMBASE. Search equations for each database included
the free-text word “split mouth” combined with a filter
designed to identify systematic reviews (see Additional
file 1) [10]. Second, we performed a full-text search of the
Cochrane Database of Systematic Reviews (CDSR) through
www.thecochranelibrary.com and archie.cochrane.org. We
also searched the Database of Abstracts of Reviews
(DARE). Third, we searched SCIRUS, a science-specific
search engine covering full-text articles. The last search
was conducted in February 2013, with no restriction on
date or language.
Two authors independently and in duplicate screened
the titles and abstracts of records retrieved by the
search, and then screened the selected full-text reports.
When the designs of selected trials were unclear in an
abstract, we always screened the full-text article. Any
disagreements were resolved by discussion.
Eligible studies were systematic reviews of therapeutic
or preventive interventions that included at least one
split-mouth RCT, as labeled by the review authors, and
at least one parallel-arm RCT in quantitative syntheses
(ie, meta-analyses). Updates of systematic reviews were
selected rather than initial versions.
From each eligible systematic review, we selected all
independent meta-analyses (defined as the comparisonbetween specific experimental and control interventions
on a given outcome). We excluded meta-analyses in
which all RCTs had a split-mouth or parallel-arm design.
Then we selected one binary or one continuous out-
come, or both if present, corresponding to the previous
criteria. In cases of multiple eligible outcomes, we chose
the primary outcome as stated by the authors or selected
the outcome with the largest number of studies. For each
meta-analysis, we selected all individual RCTs and we
excluded non-randomized studies. Finally, we identified
overlapping meta-analyses (ie, with common RCTs) and
excluded the meta- analysis that included fewer trials [11].
Data extraction
Two authors extracted the data in duplicate and inde-
pendently, with discrepancies resolved by discussion. For
each systematic review, we recorded the first author,
publication year and studied population. For each meta-
analysis, we recorded the experimental intervention, the
comparator, the outcome and the number of split-mouth
and parallel-arm RCTs.
We assessed the methods used by the authors for in-
corporating split-mouth RCTs into meta- analyses: we
assessed the presence of subgroup analyses (ie, split-
mouth RCTs and parallel-arm RCTs analyzed separately)
and/or whether one quantitative synthesis combined
split-mouth and parallel-arm RCTs; in this case, we
assessed whether the techniques described by Elbourne
2002 or Lesaffre 2009 were used [9,12]; moreover, we
assessed whether the authors calculated the standard error
of the intervention effect estimate in split- mouth RCTs
using appropriate methods (ie, statistical approaches
taking into account the paired nature of data; eg, the
techniques described by Follmann) [13].
From the systematic review, for each RCT, we ab-
stracted the first author and publication year and the
design (split-mouth or parallel-arm). From the original
RCT reports, we extracted the number of patients and,
according to type of outcome, the means and associated
SDs, or number of events, for both the experimental and
control arms.
Statistical analysis
Binary and continuous outcomes were analyzed separ-
ately. For each RCT, we derived an intervention effect
estimate and the associated sampling variance. Inter-
vention effects were measured by odds ratios (ORs)
and standardized mean differences (SMDs, or Cohen’s
d). All comparisons were coded so that the experimen-
tal intervention was compared with the comparator for
an unfavorable outcome. Binary and continuous outcomes
were coded so that an OR < 1 and SMD < 0 indicated a
beneficial effect of the experimental intervention, respect-
ively. For binary outcomes, in cases of 0-count cells, we
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all arms, the RCT was excluded.
For split-mouth RCTs, we took into account the
matched nature of data; marginal ORs were calculated
by the method of Becker and Balagtas [12,14,15]; SMDs
were estimated by taking into account the within-patient
correlation coefficient [16]. We contacted the corre-
sponding authors of all split-mouth RCTs to ask for the
required matched outcome data. If not available from the
reports and with no response from authors, we assumed a
within- patient correlation of 0.5. Sensitivity analyses with
correlation values of 0 and 0.25 yielded similar results.
For every meta-analysis, with more than one split-mouth
or parallel-arm RCT, we calculated combined intervention
effects and associated variances. We used both fixed-effects
and random-effects (restricted maximum likelihood esti-
mator) calculations. Results were similar, so we reported
results obtained with fixed-effects primarily and those ob-
tained with random-effects as sensitivity analysis.
We used a meta-epidemiological analysis to estimate
the combined difference in intervention effect estimates
between split-mouth and parallel-arm RCTs by a two-
step method [17]. For each meta-analysis with a binary
outcome, we estimated the ratio of the intervention
effect for split-mouth RCTs to that for parallel-arm
RCTs, the ratio of ORs (ROR): on a logarithmic scale,
we derived log(ROR) = log(summary OR in split-mouth
RCTs) − log(summary OR in parallel-arm RCT) and its
variance Var(log ROR) = Var[log(summary OR in split-
mouth RCTs)] + Var[(log summary OR in parallel-arm
RCTs)]. Then we estimated a combined ROR and 95%
confidence interval (CI) across meta-analyses by a
random-effects meta-analysis model (restricted max-
imum likelihood estimator). For each meta-analysis with
a continuous outcome, we estimated the difference in
intervention effect estimates between split-mouth and
parallel-arm RCTs, the difference in SMDs (ΔSMD): we
derived ΔSMD = summary SMD in split-mouth RCTs −
summary SMD in parallel-arm RCT and its variance Var
(ΔSMD) = Var[summary SMD in split-mouth RCTs] +
Var[summary SMD in parallel-arm RCTs]. Then we
estimated a combined ΔSMD across meta- analyses and
95% CI across meta-analysis by a random-effects meta-
analysis model (restricted maximum likelihood estimator).
An ROR < 1 or ΔSMD < 0 indicated that split-mouth
RCTs yielded larger intervention effect estimates than
parallel-arm RCTs. Heterogeneity in RORs or ΔSMDs
across the different meta-analyses was assessed by the I2
statistic and tau2 the between-meta-analyses variance.
We plotted the results on forest plots. We reported the
95% prediction intervals for the ROR and ΔSMD, respect-
ively, which provide a predicted range for the true dif-
ference in treatment effects between split-mouth and
parallel-arm RCTs in an individual meta-analysis.Analyses involved use of the R software (online at
http://www.R-project.org, the R Foundation for Statistical
Computing, Vienna,Austria). A 2-tailed P < 0.05 was con-
sidered statistically significant.
Results
Eligible systematic reviews and meta-analyses
The search yielded 335 potentially eligible articles. The
flow chart of selection and reasons for exclusion are in
Figure 1. We included 18 systematic reviews [18-36]; 8
were Cochrane systematic reviews [23,25-27,30,33,34,36].
The selected reviews were all published recently (range
2006 to 2013). The reviews concerned interventions for
periodontal disease (n = 9), dental surgery/implantology
(n = 6), dental caries (n = 2), and orthodontic treatment
(n = 1) (Table 1).
From the 18 systematic reviews, 42 meta-analyses were
eligible. The identification of overlapping meta-analyses
led to the exclusion of 8 meta-analyses (from 2 system-
atic reviews). Consequently, 34 meta-analyses contrib-
uted to our analysis: 15 with binary outcome data, and
19 with continuous outcome data. The median number
of RCTs per meta- analysis was 4 (range 2–16) (Table 2).
Methods used for incorporating split-mouth trials into
meta-analyses
In all systematic reviews, the authors combined split-
mouth trials together with parallel-arm trials in meta-
analyses (Table 3). For 6 of 18 systematic reviews, the
authors also meta- analyzed split-mouth and parallel-
arm trials separately in subgroup analyses. Regarding the
standard error of the intervention effect estimate in
split-mouth RCTs, in 8 reviews, how the paired nature
of data was taken into account was not clear and in another
8 reviews, the paired nature of data was imputed with
methods described by Follmann [13] when the appropriate
data were not present in RCT reports. Finally, we contacted
the authors of all split-mouth RCTs to ask for the matched
outcome data and we received 16 responses.
Characteristics of split-mouth and parallel-arm trials
The15 meta-analyses with binary outcome data involved
28 split-mouth and 28 parallel-arm RCTs; the19 meta-
analyses with continuous outcome data involved 45 split-
mouth and 48 parallel-arm RCTs, for 56 and 65 distinct
split-mouth and parallel-arm RCTs, respectively. Parallel-
arm RCTs were published later than split-mouth RCTs
(median [25%-75% percentile] 2007 [2002–2008] versus
2004 [1999–2008]); the first published RCT was a split-
mouth RCT in 20 of the 34 meta-analyses. Parallel-arm
RCTs had a larger median sample size than split-mouth
RCTs (median 40 [29–90] versus 20 [12-30]).The median
total relative weight of split-mouth RCTs in each meta-
analysis was 51% [39–71%] for the 34 meta-analyses.
335 references  
identified through database searching 
234 references 
146 references 
101 references excluded 
-17 protocols 
-84 duplicates 
18 eligible systematic reviews 
-18 meta-analyses with binary outcome 
-24 meta-analyses with continuous outcome 
88 references excluded by selection on title and abstract 
-Not a systematic review (n=26)  
-Duplicates/updated reviews (n=35) 
-Not a therapeutic intervention (n=2) 
-No or only 1 RCT included (n=11) 
-No meta-analysis performed (n=8) 
-No split-mouth RCT (n=2) 
-No parallel-arm RCT (n=4) 
128 references eliminated by selection on full-text article 
-Design of included RCTs unclear (n=4) 
-No or only 1 RCT included (n=10) 
-No meta-analysis performed (n=38) 
-No split-mouth RCT (n=44) 
-No parallel-arm RCT (n=19) 
-Unclear or no effect size reported for each RCT (n=13)  
18 eligible systematic reviews 
-15 meta-analyses with binary outcome 
-19 meta-analyses with continuous outcome 
8 overlapping meta-analyses from 2 systematic reviews 
Figure 1 Flow diagram.
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and parallel-arm trials
Among the 15 meta-analyses with binary outcome data, 8
yielded a larger intervention effect for split-mouth RCTs
(none with evidence for a difference between the twoTable 1 18 selected systematic reviews
Review Population
1. Annibali [18] Patients treated with dental im
2. Atieh [19] Patients with a clinical diagnos
3. Brignardello-Petersen [20] Patients who underwent surgic
4. Cairo [21] Patients with a clinical diagnos
5. Carrasco-Labra [22] Healthy adult subjects who un
6. Chambronne [23] Patients with gingival recession
7. Del Fabbro [24] Patients undergoing surgical p
8. Esposito [25] Patients with osteointegrated r
9. Esposito [26] Patients with chronic, aggressiv
component of at least 3 mm to
10. Esposito [27] Patients rehabilitated with imp
11. Fleming [28] Patients with full-arch, fixed, an
12. Imai [29] Adult patients with clinical sign
13. Lodi [30] Patients undergoing tooth extr
14. Mickenautsch [31] Patients requiring dental restor
15. Muller-Bolla [32] Patients > 5 years old with perm
16. Needleman [33] Patients≥ 21 years old with ch
17. Sgolastra [35] Adult patients with chronic pe
18. Yong [36] Adult patients with adrenal insestimates) and 6 a larger intervention effect for parallel-
arm RCTs (2 with evidence for a difference between the
two estimates) (see Additional file 2). Split-mouth and
parallel-arm RCTs did not differ in intervention effect
estimates: the meta-epidemiological analysis yielded aplants
is of chronic periodontitis
al removal of impacted mandibular third molars
is of Miller Class I or II localized gingival recession defect
derwent surgical removal of an impacted mandibular third molar
areas (Miller’s Class I or II > 3 mm)
rocedures for the treatment of periodontal defects and gingival recession
oot-form dental implants
e, or early onset periodontitis and intrabony defects with an intrabony
be treated
lant supported/retained prostheses
d bonded orthodontic appliances
s of gingivitis and some periodontitis
action for any indication
ation
anent molars, all caries-free or with incipient carious lesions
ronic periodontitis or periodontitis
riodontitis
ufficiency and who required surgery
Table 2 35 selected meta-analyses (15 with binary outcomes and 19 with continuous outcomes)
Meta-
analysis
Experimental intervention Comparator Binary outcome Continuous
outcome
1 Platform-switched implant restoration Platform match - Marginal bone loss
2 Scaling and root planning + antimicrobial
photodynamic therapy
Scaling and root planning - Clinical attachment
level gain
3. Low-level laser energy irradiation Nonactive comparator - Trismus
4.a. Coronally advanced flap + connective
tissue graft
Coronally advanced flap Complete root coverage Gingival recession
change
4.b. Coronally advanced flap + enamel
matrix derivative
Coronally advanced flap Complete root coverage Gingival recession
change
4.c. Coronally advanced flap + acellular
dermal matrix
Coronally advanced flap Complete root coverage Gingival recession
change
4.d. Coronally advanced flap + barrier
membranes
Coronally advanced flap + connective
tissue graft
Complete root coverage Gingival recession
change
4.e Coronally advanced flap + acellular
dermal matrix
Coronally advanced flap + connective
tissue graft
Complete root coverage Gingival recession
change
5. Secondary closure technique Primary closure technique Infectious complication Pain
6.a Guided tissue regeneration (rm) + bone
substitutes
Subepithelial connective tissue grafts - Gingival recession
change
6.b Guided tissue regeneration (rm) + bone
substitutes
Guided tissue regeneration (rm) Complete root coverage Gingival recession
change
7. Platelet-rich plasma Control - Clinical attachment
level gain
8.a Loading of osteointegreated implants
within 1 week
Loading of osteointegreated implants
after 2 months
Prosthesis failure Marginal bone level
changes
8.b Loading of osteointegreated implants
within 1 week
Loading of osteointegreated implants
between 1 week and 2 months
Prosthesis failure Marginal bone level
changes
9. Emdogain Control Probing attachment level
gain < 2 mm
-
10. Procedure with flap elevation Flapless implant insertion Implant failure -
11. 1-stage bonding (self-etch) 2-stage bonding (acid-etch) Bracket failure -
12. Dental floss Interdental brushes - Interproximal gingival
bleeding
13. Antibiotic - Pre-operative prophylaxis Placebo - Pain
14. Glass-ionomer cement Amalgam Caries -
15.a Fluoride-containing resin-based sealant Light-cured resin-based sealant Complete retention -
15.b Rubber dam Cotton rolls Complete retention -
16 Guided tissue regeneration Control - Clinical attachment
level gain
17. Scaling and root planning + Diode
laser
Scaling and root planning - Probing depth
reduction
18. Supplemental perioperative steroids Placebo - Systolic blood
pressure
rm: with resorbable membranes.
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http://www.biomedcentral.com/1471-2288/14/64combined ROR of 0.96 (95% CI 0.52–1.80, p = 0.91, I2 =
50%, 95% CI 9%–80%, and tau2 = 0.62 across meta-
analyses) (Figure 2). The associated 95% prediction
interval for the ROR was 0.19 to 5.08. Finally, when
using random-effects models for within-meta-analysis
calculations of summary effect sizes in split-mouth and
parallel-arm RCTs, it yielded a combined ROR of 0.79
(95% CI 0.47–1.32, p = 0.36).Among the 19 meta-analyses with continuous outcome
data, 8 yielded a larger intervention effect for split-mouth
RCTs (2 with evidence for a difference between the two
estimates) and 9 a larger intervention effect for parallel-
arm RCTs (4 with evidence for a difference between the
two estimates) (see Additional file 2). Split-mouth and
parallel- arm RCTs did not differ in intervention effect
estimates: the meta-epidemiological analysis yielded a
Table 3 Methods used by review authors to incorporate split-mouth RCTs into meta-analyses
Review Split-mouth and parallel
arm RCTs combined
Standard error of the treatment effect estimate in split-mouth RCTs
Together Separately (subgroups)
1. Annibali [18] Yes Yes Imputed using Follmann [13], with the appropriate data not presented
2. Atieh [19] Yes No Not clear
3. Brignardello-Petersen [20] Yes Yes Within-patient correlation assumed equal to 0
4. Cairo [21] Yes No Imputed using Follmann [13], with the appropriate data not presented
5. Carrasco-Labra [22] Yes Yes Imputed using Follmann [13], with the appropriate data not presented.
Within-patient correlation assumed equal to 0.75
6. Chambronne [23] Yes Yes Imputed using Follmann [13], with the appropriate data not presented
7. Del Fabbro [24] Yes No Not clear
8. Esposito [25] Yes No Imputed using Follmann [13], with the appropriate data not presented
9. Esposito [26] Yes Yes Imputed using Follmann [13], with the appropriate data not presented.
Within-patient correlation assumed equal to 0.25 (median ICC in similar
review, Needleman [33])
10. Esposito [27] Yes No Imputed using Follmann [13], with the appropriate data not presented
11. Fleming [28] Yes No Calculated using Borenstein [16]
12. Imai [29] Yes No Not clear
13. Lodi [30] Yes No Not clear
14. Mickenautsch [31] Yes No Not clear
15. Muller-Bolla [32] Yes No Not clear
16. Needleman [33] Yes Yes Imputed using Follmann [13], with the appropriate data not presented.
Within-patient correlation assumed equal to 0.25
17. Sgolastra [35] Yes No Not clear
18. Yong [36] Yes No Not clear
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I2 = 56%, 95% CI 21%–82%, and tau2 = 0.12 across meta-
analyses) (Figure 3). The associated 95% prediction inter-
val for the ΔSMD was −0.63 to 0.79. Finally, when using
random-effects models for within-meta-analysis calcu-
lations of summary effect sizes in split-mouth and
parallel-arm RCTs, it yielded a combined ΔSMD of 0.05
(95% CI −0.21–0.30, p = 0.73).
In all, 6 of 8 meta-analyses showing differences between
split-mouth and parallel-arm RCTs beyond chance did not
meta-analyze split-mouth and parallel-arm RCTs separ-
ately in subgroup analyses.
Discussion
In our meta-epidemiological study, we found that split-
mouth trials contributed half of the evidence in meta-
analyses. Contrary to the recommendations by Lesaffre
et al. and the Cochrane Oral Health group, most sys-
tematic reviews did not meta-analyze split-mouth and
parallel-arm trials separately in subgroup analyses [37].
Moreover, most reviews did not report explicitly how
split-mouth RCTs were handled in meta-analyses, while
others approximated a paired analysis by imputing within-
patient correlations. Finally, our meta- epidemiological
study did not provide sufficient evidence for a systematicdifference in intervention effect estimates between split-
mouth and parallel-arm RCTs, both for continuous and
binary outcome data.
The main difference between split-mouth and parallel-
arm trials with regard to mechanisms of bias is that, in
split-mouth trials, interventions may have effects on
parts of the dentition other than those to which they
were assigned; these carry-over effects put split-mouth
trials at risk of bias. However, no method exists to assess
or test the extent of carry-across effects in a split-mouth
trial. As a consequence, the possibility of carry-over ef-
fects should be considered before deciding on whether a
split-mouth design should be used. As far as we can
judge a posteriori, the effects of interventions assessed
in the reviews selected for our meta-epidemiological
study were always localized.
Previous meta-epidemiological studies showed that
individual study processes (eg, inadequate allocation
concealment, non-blinding [38]) or nonprocess-related
factors (eg, whether a study was conducted at a single
center [39]) may put a randomized trial at risk of bias
[40]. Very few meta-epidemiological studies have assessed
if study designs itself could be associated with treatment
effect estimates. Lathyris et al. focused on the cross-
over design, which is relevant to oral health research
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 14.46%     3.56 [ 2.07 ,   6.13 ]
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  9.83%     0.69 [ 0.20 ,   2.41 ]
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  7.59%     0.45 [ 0.09 ,   2.32 ]
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yield larger treatment effect
Parallel RCTs 
yield larger treatment effect
I² = 50%
Random-effects meta-analysis (REML)
Figure 2 Difference in intervention effect estimates between split-mouth and parallel-arm randomized controlled trials for binary
outcome data.
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http://www.biomedcentral.com/1471-2288/14/64and biomedical research in general; the results of cross-
over trials tended to agree with those of parallel-arm tri-
als [41]. Here, we focused on the split-mouth design,
which is popular in oral health research. This type of
design is in fact also relevant to other fields of biomedical
research in general, in which split- body studies allocate
the interventions to separate parts of the body of each par-
ticipant. However, these trials are infrequent (about 2-3%
of randomized trials indexed in Pubmed) [42,43] and we
could find only one meta-analysis including at least one
split-body trial and at least one parallel-arm trial [44].
Our findings are based on recently published system-
atic reviews covering a fair range of conditions and in-
terventions in oral healthcare. Consequently, our results
are more generalizable than could be obtained with
focus on a particular topic. Our study has several limita-
tions. We selected a relatively small number of system-
atic reviews for our meta-epidemiological study. It is
difficult to identify reviews with both parallel-arm and
split-mouth trials with usual strategies and we acknow-
ledge that unidentified reviews may exist. However, we
systematically searched for both Cochrane and non-Cochrane reviews, including a search of full-text arti-
cles indexed in the Cochrane library and in the Scirus
database. Unfortunately, the latter service is no longer
running. We acknowledge that searching additional re-
gional databases (e.g., LILACS, PASCAL) and full-text
databases (e.g., HighWire Press, Google Scholar) may
be very useful to identify potentially eligible systematic
reviews. Eligible reviews may be missing because of
reporting bias (including location bias and language
bias). However, reporting bias is usually driven by the
magnitude/direction and statistical significance of treat-
ment effects. We see no reason for reviews to be missing
because of the difference in treatment effect estimates be-
tween split-mouth and parallel-arm RCTs. As a conse-
quence, the impact of missing reviews is unpredictable
and probably limited on our meta-epidemiological study.
On top of the relatively small number of selected reviews,
the number of split-mouth and parallel-arm RCTs in each
meta-analysis was small. Meta-analyses typically include a
limited number of trials: the median number of trials in a
large sample of Cochrane meta- analyses was 3 [45]. The
consequence is uncertainty in the difference between the 2
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  5.19%     0.80 [  0.11 ,  1.48 ]
  4.78%     0.02 [ -0.72 ,  0.77 ]
  4.12%    -0.13 [ -0.97 ,  0.71 ]
  8.00%    -0.58 [ -0.96 , -0.20 ]
  6.56%     0.44 [ -0.08 ,  0.97 ]







yield larger treatment effect
Parallel RCTs 
yield larger treatment effect
I² = 56%
Random-effects meta-analysis (REML)
Figure 3 Difference in intervention effect estimates between split-mouth and parallel-arm randomized controlled trials for continuous
outcome data.
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http://www.biomedcentral.com/1471-2288/14/64study designs. Because of these limitations, and as it is to
our knowledge the first meta- epidemiological investiga-
tion on the subject, we acknowledge that these results
should be replicated, by including additional comparisons
between the two designs as they become available. A sec-
ond caveat is that we did not assess risk of bias within
each RCT and we cannot assess meta-confounding. The
split-mouth and parallel-arm trials in the selected reviews
may differ in their methodological quality. However, it
would be difficult to assess the risk of bias in selected
split-mouth trials because assessing internal validity re-
quires adequate reporting and split-mouth trials fre-
quently exhibit poor or inadequate reporting [37].
Moreover, meta-confounding because of systematic dif-
ferences in risk of bias between split- mouth and
parallel-arm trials would be an alternative explanation
for an association between trial design and treatment
effect estimates but we did not find evidence of such an
association.
Our results support the use of all available evidence in
systematic reviews, including that from split-mouth andparallel-arm RCTs, and authors should consider results
from both trial designs in syntheses of oral health pri-
mary research. The incorporation of split-mouth RCTs
should follow adequate methods [9,12]; moreover, for
each split-mouth RCT, the difference between groups
rather than estimates per group must be used and the
standard error of the intervention effect estimate should
take the matched nature of data into account [13].
Because trials in this field are frequently small, one
should not be confident that the true intervention effect
lies closer to the effect estimates from parallel-arm or
split-mouth trials. Even when combining split-mouth
and parallel-arm RCTs in the same meta-analysis, con-
sideration should be given to potential differences be-
tween the different types of trials in subgroup analyses,
until there is more evidence that the two designs do not
systematically differ. Meta- analysts should also consider
issues of external validity because split-mouth trials
include patients with symmetrical caries or lesions who
could differ from other patients in terms of possibly
poorer brushing and dietary behavior.
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Our meta-epidemiological study did not provide suffi-
cient evidence for a difference in intervention effect
estimates derived from split-mouth and parallel-arm
RCTs. Systematic review authors should consider in-
cluding split-mouth RCTs in their meta-analyses with
suitable and appropriate analysis.
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